Roberto Salgado

Active 1999–2026

191
Papers
35,594
Citations
91
h-index
171
i10-index

Citations

Citations per year for Roberto Salgado1987: 1 citations1993: 1 citations1999: 4 citations2000: 7 citations2001: 8 citations2002: 15 citations2003: 17 citations2004: 29 citations2005: 14 citations2006: 20 citations2007: 28 citations2008: 23 citations2009: 17 citations2010: 21 citations2011: 28 citations2012: 35 citations2013: 44 citations2014: 94 citations2015: 195 citations2016: 285 citations2017: 461 citations2018: 416 citations2019: 1,415 citations2020: 1,950 citations2021: 2,370 citations2022: 1,964 citations2023: 1,621 citations2024: 2,502 citations2025: 1,590 citations2026: 52 citations1988–1992: no citations, so these years are not shown1994–1998: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,674 citing papers, 21.3% of this breakdownChina: 2,566 citing papers, 14.9% of this breakdownUnited Kingdom: 1,031 citing papers, 6% of this breakdownItaly: 964 citing papers, 5.6% of this breakdownGermany: 747 citing papers, 4.3% of this breakdownFrance: 701 citing papers, 4.1% of this breakdownAustralia: 590 citing papers, 3.4% of this breakdownSpain: 531 citing papers, 3.1% of this breakdownBelgium: 510 citing papers, 3% of this breakdownNetherlands: 501 citing papers, 2.9% of this breakdownJapan: 495 citing papers, 2.9% of this breakdownCanada: 487 citing papers, 2.8% of this breakdown
0%21.3%Other 25.7%

Fields

  • Medicine56.1%
  • Biochemistry, Genetics and Molecular Biology26.7%
  • Immunology and Microbiology10.4%
  • Computer Science3.7%
  • Engineering1.2%
  • Neuroscience0.4%
  • Other1.5%

Topics

  • Cancer Immunotherapy and Biomarkers13.6%
  • Immunotherapy and Immune Responses6.6%
  • Breast Cancer Treatment Studies4.3%
  • Cancer Genomics and Diagnostics3.8%
  • Immune Cell Function and Interaction3.5%
  • Immune cells in cancer3.2%
  • Other65%

Coauthors

All papers

Open in search
  1. The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen Willard‐Gallo, Sherene Loi - Annals of Oncology 2014 cited by 3,136

  2. Immune induction strategies in metastatic triple-negative breast cancer to enhance the sensitivity to PD-1 blockade: the TONIC trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sabine C. Linn, Ton N. Schumacher, Christian U. Blank, Marleen Kok - Nature Medicine 2019 cited by 889

  3. Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2018 cited by 991

  4. Neoantigen-directed immune escape in lung cancer evolution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2019 cited by 993

  5. CD4+ follicular helper T cell infiltration predicts breast cancer survival

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2013 cited by 1,050

  6. RETRACTED ARTICLE: Antibodies against endogenous retroviruses promote lung cancer immunotherapy

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emilia L. Lim, Mark S. Hill, Gareth A. Wilson, Daniel E. Cook, Nicolai J. Birkbak, Axel Behrens, Nadia Yousaf, Sanjay Popat, Allan Hackshaw, Andrew Rowan, Ariana Huebner, Brittany Campbell, Chris Bailey, Claudia Lee, Dhruva Biswas, Emma Colliver, Foteini Athanasopoulou, Hao-Ran Zhai, Jayant K. Rane, Kristiana Grigoriadis, Michelle Dietzen, Michelle Leung, Mihaela Angelova, Olivia Lucas, Othman Al‐Sawaf, Rachel Rosenthal, Jérôme Nicod, Abigail Bunkum, Antonia Toncheva, Christopher Abbosh, Corentin Richard, Cristina Naceur‐Lombardelli, Francisco Gimeno-Valiente, Jie Min Lam, Kerstin Thol, Krupa Thakkar, Mariana Werner Sunderland, Martin Förster, Nnennaya Kanu, Paulina Prymas, Robert B. Bentham, Sadegh Saghafinia, Sergio A. Quezada, Sharon Vanloo, Simone Zaccaria, Siow Ming Lee, Sonya Hessey, Wing Kin Liu, Dionysis Papadatos-Pastos, James M. Wilson, Sarah Benafif, Tanya Ahmad, Elaine Borg, Mary Falzon, Reena Khiroya, Teresa Marafioti, Abigail Sharp, Camilla Pilotti, Harjot Kaur Dhanda, Kitty S. Chan, Nicole Gower, Rachel Leslie, Sean Smith, Andrew G. Nicholson, Eric Lim, Javier Herrero, Carla Castignani, Elizabeth Larose Cadieux, Jonas Demeulemeester, Peter Van Loo and 231 more - Nature 2023 cited by 249

  7. Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working Group

    Authors: , , , , , , , , , , , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2020 cited by 733

  8. The evolution of lung cancer and impact of subclonal selection in TRACERx

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rachel Rosenthal, Clare Puttick, Sonya Hessey, Claudia Lee, Paulina Prymas, Antonia Toncheva, Jon Smith, Xing Wei, Jérôme Nicod, Gillian Price, Keith M. Kerr, Babu Naidu, Gary Middleton, Kevin G. Blyth, Dean A. Fennell, Martin Förster, Siow Ming Lee, Mary Falzon, Madeleine Hewish, Michael Shackcloth, Eric Lim, Sarah Benafif, Peter Russell, Ekaterini Boleti, Matthew Krebs, J.F. Lester, Dionysis Papadatos-Pastos, Tanya Ahmad, Ricky M. Thakrar, David Lawrence, Neal Navani, Sam M. Janes, Caroline Dive, Fiona Blackhall, Yvonne Summers, Judith Cave, Teresa Marafioti, Javier Herrero, Sergio A. Quezada, Karl S. Peggs, Roland F. Schwarz, Peter Van Loo, Daniël M. Miedema, Nicolai J. Birkbak, Crispin T. Hiley, Allan Hackshaw, Simone Zaccaria, John Le Quesne, Peter Van Loo, Amrita Bajaj, Apostolos Nakas, Azmina Sodha-Ramdeen, Keng Ang, Mohamad Tufail, Mohammed Fiyaz Chowdhry, Molly Scotland, Rebecca Boyles, Sridhar Rathinam, Claire Wilson, Domenic Marrone, Sean Dulloo, Gurdeep Matharu, Jacqui Shaw, Joan Riley, Lindsay Primrose, Heather Cheyne, Mohammed S. Khalil, Shirley Richardson, Tracey Cruickshank, Kayleigh Gilbert and 187 more - Nature 2023 cited by 308

  9. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Fabrice André, G. Curigliano - Annals of Oncology 2023 cited by 299

  10. Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 cited by 891

  11. The 2019 World Health Organization classification of tumours of the breast

    Authors: , , , , , , , , , , , , , , , , , , - Histopathology 2020 cited by 1,074

  12. Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2017 cited by 933

  13. Trastuzumab emtansine plus atezolizumab versus trastuzumab emtansine plus placebo in previously treated, HER2-positive advanced breast cancer (KATE2): a phase 2, multicentre, randomised, double-blind trial

    Authors: , , , , , , , , , , , , , , , - The Lancet Oncology 2020 cited by 375

  14. Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non–Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michail Ignatiadis, Sunil Badve, Robert H. Pierce, Giuseppe Viale, Nicolas Sirtaine, Frédérique Penault‐Llorca, Tomohagu Sugie, Susan Fineberg, Soonmyung Paik, Ashok Srinivasan, Andrea L. Richardson, Yihong Wang, Ewa Chmielik, Jane Brock, Douglas B. Johnson, Justin M. Balko, Stephan Wienert, Veerle Bossuyt, Stefan Michiels, Nils Ternès, Nicole Burchardi, Stephen J. Luen, Peter Savas, Frederick Klauschen, Peter H. Watson, Brad H. Nelson, Carmen Criscitiello, Sandra A. O’Toole, Denis Larsimont, Roland de Wind, Giuseppe Curigliano, Fabrice André, Magali Lacroix‐Triki, Marc J. van de Vijver, Federico Rojo, Giuseppe Floris, Shahinaz Bedri, Joseph A. Sparano, David L. Rimm, Torsten O. Nielsen, Zuzana Kos, Stephen M. Hewitt, Baljit Singh, Gelareh Farshid, Sibylle Loibl, Kimberly H. Allison, Nadine Tung, Sylvia Adams, Karen Willard‐Gallo, Hugo M. Horlings, Leena Gandhi, André Moreira, Fred R. Hirsch, Maria Vittoria Dieci, María Urbanowicz, Iva Brčić, Konstanty Korski, Fabien Gaire, Hartmut Koeppen, Amy Lo, Jennifer M. Giltnane, Marlon C. Rebelatto, Keith E. Steele, Jiping Zha, Kenneth Emancipator, Jonathan Juco, Carsten Denkert, Jorge S. Reis‐Filho, Sherene Loi, Stephen B. Fox - Advances in Anatomic Pathology 2017 cited by 799

  15. Melanoma-specific MHC-II expression represents a tumour-autonomous phenotype and predicts response to anti-PD-1/PD-L1 therapy

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature Communications 2016 cited by 572

  16. Clinical relevance of host immunity in breast cancer: from TILs to the clinic

    Authors: , , , , , , - Nature Reviews Clinical Oncology 2015 cited by 904

  17. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2013 cited by 1,647

  18. Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2019 cited by 427

  19. The evolution of non-small cell lung cancer metastases in TRACERx

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Emma Nye, Richard Stone, Dean A. Fennell, Gillian Price, Keith M. Kerr, Babu Naidu, Gary Middleton, Yvonne Summers, Colin R. Lindsay, Fiona Blackhall, Judith Cave, Kevin G. Blyth, Arjun Nair, Asia Ahmed, Magali N. Taylor, Alexander James Procter, Mary Falzon, David Lawrence, Neal Navani, Ricky M. Thakrar, Sam M. Janes, Dionysis Papadatos-Pastos, Martin Förster, Siow Ming Lee, Tanya Ahmad, Sergio A. Quezada, Karl S. Peggs, Peter Van Loo, Caroline Dive, Allan Hackshaw, Nicolai J. Birkbak, Simone Zaccaria, J.F. Lester, Amrita Bajaj, Apostolos Nakas, Azmina Sodha-Ramdeen, Keng Ang, Mohamad Tufail, Mohammed Fiyaz Chowdhry, Molly Scotland, Rebecca Boyles, Sridhar Rathinam, Claire Wilson, Domenic Marrone, Sean Dulloo, Gurdeep Matharu, Jacqui Shaw, Joan Riley, Lindsay Primrose, Ekaterini Boleti, Heather Cheyne, Mohammed S. Khalil, Shirley Richardson, Tracey Cruickshank, Sarah Benafif, Kayleigh Gilbert, Akshay J. Patel, Aya Osman, Christer Lacson, Gerald Langman, Helen Shackleford, Madava Djearaman, Salma Kadiri, Angela Leek, Jack Davies Hodgkinson, Nicola Totten, Ángeles Montero, Elaine Smith, Eustace Fontaine, Felice Granato and 186 more - Nature 2023 cited by 236

  20. Genomic–transcriptomic evolution in lung cancer and metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , James Clements, Daniel E. Cook, Rachel Rosenthal, Gareth A. Wilson, Alexander M. Frankell, Sophie de Carné Trécesson, Philip East, Nnennaya Kanu, Kevin Litchfield, Nicolai J. Birkbak, Allan Hackshaw, Stephan Beck, Peter Van Loo, Mariam Jamal‐Hanjani, Nicholas McGranahan, Charles Swanton, Maise Al Bakir, Emilia L. Lim, Alexander M. Frankell, Kevin Litchfield, Nicolai J. Birkbak, Peter Van Loo, J.F. Lester, Amrita Bajaj, Apostolos Nakas, Azmina Sodha-Ramdeen, Keng Ang, Mohamad Tufail, Mohammed Fiyaz Chowdhry, Molly Scotland, Rebecca Boyles, Sridhar Rathinam, Claire Wilson, Domenic Marrone, Sean Dulloo, Dean A. Fennell, Gurdeep Matharu, Jacqui Shaw, Joan Riley, Lindsay Primrose, Ekaterini Boleti, Heather Cheyne, Mohammed S. Khalil, Shirley Richardson, Tracey Cruickshank, Gillian Price, Keith M. Kerr, Sarah Benafif, Kayleigh Gilbert, Babu Naidu, Akshay J. Patel, Aya Osman, Christer Lacson, Gerald Langman, Helen Shackleford, Madava Djearaman, Salma Kadiri, Gary Middleton, Angela Leek, Jack Davies Hodgkinson, Nicola Totten, Ángeles Montero, Elaine Smith, Eustace Fontaine, Felice Granato, Helen Doran, Juliette Novasio, Kendadai Rammohan, Leena Dennis Joseph, Paul Bishop and 197 more - Nature 2023 cited by 198

  21. Spatial immunophenotypes predict response to anti-PD1 treatment and capture distinct paths of T cell evasion in triple negative breast cancer

    Authors: , , , , , , , , , , , , , , - Nature Communications 2021 cited by 251

  22. Towards targeting the breast cancer immune microenvironment

    Authors: , , , , , , , , - Nature reviews. Cancer 2024 cited by 304

  23. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

    Authors: , , , , , , , , , , , , , , , - Annals of Oncology 2014 cited by 1,270

  24. Determinants of anti-PD-1 response and resistance in clear cell renal cell carcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tom Lund, Kim Dhillon, Marcos Duran Vasquez, Ehsan Ghorani, Hang Xu, Charlotte Spencer, José I. López, Anna Green, Ula Mahadeva, Elaine Borg, Miriam Mitchison, David A. Moore, Ian Proctor, Mary Falzon, Lisa Pickering, Andrew J.S. Furness, James L. Reading, Roberto Salgado, Teresa Marafioti, Mariam Jamal‐Hanjani, Chris Abbosh, Kai‐Keen Shiu, John Bridgewater, Daniel Hochhauser, Martin Förster, Siow Ming Lee, Tanya Ahmad, Dionysis Papadatos-Pastos, Sam M. Janes, Peter Van Loo, Katey S.S. Enfield, Nicholas McGranahan, Ariana Huebner, Stephan Beck, Peter J. Parker, Henning Walczak, Tariq Enver, Robert E. Hynds, Ron Sinclair, Chi-wah Lok, Zoe Rhodes, David A. Moore, Reena Khiroya, Giorgia Trevisan, Peter Ellery, Mark Linch, Sebastian Brandner, Crispin T. Hiley, Selvaraju Veeriah, Maryam Razaq, Heather Shaw, G. Attard, Mita Afroza Akther, Cristina Naceur‐Lombardelli, Lizi Manzano, Maise Al-Bakir, Simranpreet Summan, Nnenna Kanu, Sophia Ward, Uzma Asghar, Emilia L. Lim, Faye Gishen, Adrian Tookman, Paddy Stone, Caroline Stirling, Nikki Hunter, Sarah Vaughan, Mary Mangwende, Lavinia Spain, Haixi Yan and 105 more - Cancer Cell 2021 cited by 256